Bioprocess Bags Market Report 2026

The bioprocess bags market size has grown rapidly in recent years. It will grow from $3.83 billion in 2025 to $4.44 billion in 2026 at a compound annual growth rate (CAGR) of 16.1%. The growth in the historic period can be attributed to growth in biopharmaceutical manufacturing, increasing adoption of disposable technologies, expansion of contract manufacturing services, rising focus on process flexibility, availability of standardized single-use components.

The bioprocess bags market size is expected to see rapid growth in the next few years. It will grow to $8.14 billion in 2030 at a compound annual growth rate (CAGR) of 16.3%. The growth in the forecast period can be attributed to increasing demand for biologics and vaccines, expansion of cell and gene therapy production, rising investments in modular bioprocessing facilities, growing emphasis on cost-efficient manufacturing, increasing regulatory support for single-use systems. Major trends in the forecast period include increasing adoption of single-use bioprocessing systems, rising demand for sterile disposable containers, growing use of 3D bioprocess bags in cell culture, expansion of flexible manufacturing workflows, enhanced focus on contamination risk reduction.

The rapid expansion of biotechnology companies is anticipated to drive the growth of the bioprocess bag market in the coming years. Biotechnology firms utilize biological knowledge, tools, and techniques to develop products and services across various industries. Bioprocess bags offer multiple advantages for the biotechnology sector, including lower environmental impact, flexibility, cost efficiency, time savings, and contamination prevention. For example, in January 2024, LondonLovesTech, a UK-based digital media and technology news publisher, reported that biotech companies and startups raised $136.3 billion in 2023, indicating that funding activity remained above pre-pandemic levels. As a result, the rapid expansion of biotechnology companies is fueling the bioprocess bag market.

Major companies in the bioprocess bag market are introducing new products, such as single-use process container films, to strengthen their position in the market. Single-use process container films are flexible films or materials specifically developed for constructing single-use process containers used in bioprocessing and pharmaceutical manufacturing. For example, in April 2023, Merck KGaA, a Germany-based pharmaceutical company, introduced the Ultimus Single-Use Process Container Film, an advanced solution designed to tackle challenges in bioprocessing liquid applications. Built with a proprietary woven nylon structure, the Ultimus film delivers exceptional durability and leak resistance, offering 10 times higher abrasion resistance, 2.8 times greater tensile strength, and double the puncture strength compared to other single-use bioprocessing films. This innovation aims to reduce disruptions in manufacturing processes and improve operational efficiency. Furthermore, the Ultimus Single-Use Process Container Film features an animal origin-free contact resin, intended to provide a low extractable profile that meets strict regulatory requirements and industry standards.

In March 2023, Sartorius, a Germany-based supplier of pharmaceutical and laboratory equipment, acquired Polyplus for $2.6 billion. Through this acquisition, Sartorius intends to strengthen its capabilities in the rapidly growing field of cell and gene therapies. Polyplus, a France-based biotechnology company, focuses on advanced biologic production and provides cell and gene therapy solutions from research to commercial scale.

Major companies operating in the bioprocess bags market are Saint-Gobain Group, Charter Medical LLC, Thermo Fisher Scientific Inc., 3M Company, Danaher Corporation, Merck KGaA, GE Healthcare, Parker Hannifin Corporation, Corning Incorporated, Avantor Inc., Lonza Group, GEA Group Aktiengesellschaft, Sartorius AG, Entegris Inc., W. L. Gore & Associates Inc., Repligen Corporation, ESI Technologies Group, Colder Products Company, CellBios Healthcare and Lifesciences Pvt Ltd., PBS Biotech.

North America was the largest region in the bioprocess bags market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioprocess bags market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the bioprocess bags market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the bioprocess bags market by increasing costs of imported polymer films, connectors, tubing assemblies, filters, and sterilization components used in disposable bioprocessing systems. Biopharmaceutical manufacturers in North America and Europe are most affected due to dependence on imported single-use materials, while Asia-Pacific faces cost pressure on bag exports. These tariffs are raising production costs and impacting supply continuity. However, they are also encouraging domestic polymer production, localized assembly of bioprocess components, and long-term investments in regional single-use manufacturing capacity.

The bioprocess bags market research report is one of a series of new reports that provides bioprocess bags market statistics, including bioprocess bags industry global market size, regional shares, competitors with a bioprocess bags market share, detailed bioprocess bags market segments, market trends and opportunities, and any further data you may need to thrive in the bioprocess bags industry. This bioprocess bags market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Bioprocess bags are specialized vessels that offer a sterile and regulated environment for cultivating cells or microorganisms. These bags are utilized in the biotechnology and biopharmaceutical industries to manufacture biological products.

The primary types of bioprocess bags include 2D bioprocess bags, 3D bioprocess bags, and others. 2D bioprocess bags are flexible containers that have a flat, two-dimensional shape when empty or prior to filling. The workflows encompass upstream processes, downstream processes, and process development, with capacities ranging from small, medium, large, to extra-large. These bags are utilized in various applications such as buffer and media storage, cell culture, cell separation and harvest, chromatography feed and collection, ultrafiltration and diafiltration, intermediate and final product storage, and others, and are used by end-users including pharmaceutical companies, biopharmaceutical companies, biotechnology labs, and academic laboratories.

The bioprocess bags market consists of sales of wave rocker bags, single-use mixing systems, and filter bag systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.